Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 2/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.46 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.44 |
| ▸ | MME | P08473 | 2/20 | 0.43 |
| ▸ | CDYL2 | Q8N8U2 | 2/20 | 0.43 |
| ▸ | CTSB | P07858 | 2/20 | 0.42 |
| ▸ | CBX7 | O95931 | 1/20 | 0.42 |
| ▸ | CBX8 | Q9HC52 | 1/20 | 0.42 |
| ▸ | CTSL | P07711 | 2/20 | 0.41 |
| ▸ | CTSS | P25774 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
| ▸ | GRPR | P30550 | 1/20 | 0.41 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1275443 | 1.00 | OPRM1 (0.46) | OPRM1OPRD1OPRK1GPR139MME | |
| SCHEMBL17925467 | 1.00 | OPRM1 (0.46) | OPRM1OPRD1OPRK1GPR139MME | |
| Hydrochloric Acid SCHEMBL30196080 | 0.99 | OPRM1 (0.46) | OPRM1OPRD1OPRK1GPR139MME | |
| Water SCHEMBL28629638 | 0.99 | OPRM1 (0.46) | OPRM1OPRD1OPRK1GPR139MME | |
| Water SCHEMBL1433025 | 0.99 | OPRM1 (0.46) | OPRM1OPRD1OPRK1GPR139MME | |
| Water SCHEMBL1433018 | 0.99 | OPRM1 (0.46) | OPRM1OPRD1OPRK1GPR139MME | |
| SCHEMBL316943 | 0.93 | OPRD1 (0.42) | OPRM1OPRD1OPRK1GRPR | |
| Hippuric Acid SCHEMBL1838491 | 0.93 | OPRD1 (0.49) | OPRM1OPRD1OPRK1CDYL2CTSB | |
| SCHEMBL11330795 | 0.92 | OPRM1 (0.42) | OPRM1OPRD1OPRK1MMECDYL2 | |
| SCHEMBL11330871 | 0.90 | OPRM1 (0.40) | OPRM1OPRD1OPRK1MMECDYL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 375 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110438074-A | A kind of immunocyte recovery culture solution and preparation method thereof | GUANGZHOU SHAAI BIOLOGICAL TECH CO LTD | 2019-11-12 | — | — | CN | claimed |
| CN-107325147-A | The screening technique of fulvoushair honeysuckle flower moderate resistance hypertensin conversion enzyme activity composition | 滨州医学院 | 2017-11-07 | — | — | CN | claimed |
| CN-101696233-B | Albumin angiotensin converting enzyme inhibition peptide and preparation method thereof | JILIN UNIVERSITY (CN) | 2012-02-01 | — | — | CN | claimed |
| US-20080171698-A1 | Anti-hypertensive molecules and process for preparation thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH. | 2008-07-17 | — | — | US | claimed |
| CN-101020714-A | Earthworm protein with function of lowering blood pressure and its prepn process | TANG SHENGJIAN (CN) | 2007-08-22 | — | — | CN | claimed |
| US-20050032709-A1 | Anti-hypertensive molecules and process for preparation thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2005-02-10 | — | — | US | claimed |
| WO-2004087743-A2 | ANTI-HYPERTENSIVE PEPTIDE DERIVATIVES AND PROCESS FOR PREPARATION THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2004-10-14 | — | — | WO | claimed |
| CN-121270657-B | Blood protein accurate active peptide with functions of tonifying qi and blood, improving microcirculation and promoting vasodilation, and preparation method and application thereof | XIAMEN YUANZHIDAO BIOTECH Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| EP-4374709-A1 | METHOD FOR PRODUCING BIOACTIVE PEPTIDES OBTAINED FROM WHEY USING ENZYMES OF PLANT ORIGIN | Pontificia Universidad Católica de Chile (CL) | 2024-05-29 | — | — | EP | disclosed |
| CN-117534727-B | Preparation method and application of food-borne antihypertensive peptide | 中国药科大学 | 2024-04-19 | — | — | CN | disclosed |
| CN-117343132-B | ACE (angiotensin converting enzyme) inhibitory peptide derived from salmon skin and preparation method thereof | 山东省农业科学院 | 2024-03-12 | — | — | CN | disclosed |
| CN-117534727-A | Preparation method and application of food-borne antihypertensive peptide | 中国药科大学 | 2024-02-09 | — | — | CN | disclosed |
| CN-117343132-A | ACE (angiotensin converting enzyme) inhibitory peptide derived from salmon skin and preparation method thereof | 山东省农业科学院 | 2024-01-05 | — | — | CN | disclosed |
| US-4256751-A | HYPOTENSIVE AGENTS | TANABE SEIYAKU CO., LTD. (JP) | 1981-03-17 | — | — | US | disclosed |
| EP-0024309-A2 | Triazolopyridazine derivatives, process and intermediates for their preparation and medicaments containing them | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-03-04 | — | — | EP | disclosed |
| EP-0018549-A2 | Tetrahydroisoquinoline compounds, process for preparing them and pharmaceutical compositions containing them | Tanabe Seiyaku Co., Ltd. (JP) | 1980-11-12 | — | — | EP | disclosed |
| US-4226775-A | HYPOTENSIVE AGENTS | AMERICAN CYANAMID COMPANY (US) | 1980-10-07 | — | — | US | disclosed |
| EP-0012845-A1 | Tetrahydroisoquinoline compounds, process for preparing same and pharmaceutical compositions containing them | Tanabe Seiyaku Co., Ltd. (JP) | 1980-07-09 | — | — | EP | disclosed |
| EP-0010347-A1 | Novel substituted omega-aroyl(propionyl or butyryl)-L-prolines, pharmaceutical compositions containing them and processes for their preparation | AMERICAN CYANAMID COMPANY (US) | 1980-04-30 | — | — | EP | disclosed |
| US-3947575-A | Peptides as argiotensin converting enzyme inhibitors | E. R. SQUIBB & SONS, INC. (US) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171698-A1 | Anti-hypertensive molecules and process for preparation thereof | REN, ACE, AGT | OPRM1 3426/4885OPRD1 3578/4885OPRK1 1440/4885 |
| US-20050032709-A1 | Anti-hypertensive molecules and process for preparation thereof | AGT, ACE, REN | OPRM1 2972/4885OPRD1 2814/4885OPRK1 1196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.